What is TTK Healthcare Ltd (TTKHLTCARE) share price return in the past 10 years?

TTK Healthcare Ltd share price has appreciated 0% annually (CAGR) over the past ten years.

What is the share price of TTK Healthcare Ltd (TTKHLTCARE)?

Company share prices are keep on changing according to the market conditions. The current trading price of TTK Healthcare Ltd (TTKHLTCARE) on 10-Jun-2026 11:47:00 at 11:47 is 920.00.

What is the P/E ratio of TTK Healthcare?

The latest standalone P/E ratio of TTK Healthcare as of 10-Jun-2026 is 19.53.

What is the P/B ratio of TTK Healthcare Ltd (TTKHLTCARE)?

The latest standalone P/B ratio of TTK Healthcare Ltd (TTKHLTCARE) as of 10-Jun-2026 is 1.16.

What is the 52-week high and low of TTK Healthcare Ltd (TTKHLTCARE)?

The 52-week high of TTK Healthcare Ltd (TTKHLTCARE) is Rs. 1402.00 and the 52-week low is Rs. 737.00.

TTK Healthcare Ltd (TTKHLTCARE) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: TTK Healthcare Ltd (TTKHLTCARE)
Brand: TTK Healthcare

Key Metrics

Valuation Multiples

Market Cap

₹1,283 Cr.

Current Price

₹920

52-Week Low / High

₹737 / 1,402

TTM EPS

₹46.5

TTM Sales

₹857 Cr.

Book Value per Share

₹785.9

P/E Ratio

19.53

Lower than its 5-year historical median

Industry PE

123.9

Price to Book (P/B)

1.16

Lower than its 5-year historical median

Price to Sales (P/S)

1.50

Lower than its 5-year historical median

EV/EBITDA

6.83

Lower than its 5-year historical median

Dividend Yield

0.84%

Profitability Efficiency

Return on Equity (ROE)

7.94%

Outperforms industry median

Return on Capital Employed (ROCE)

10.63%

Outperforms industry median

Return on Assets (ROA)

6.60%

Operating Profit Margin

4.3%

Net Profit Margin

10.19%

Gross Profit Margin

12.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

6.47%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-6.7%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

29.95%

Asset Quality

Promoter Holding

74.56%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹1,096 Cr.

Equity

₹14.1 Cr.

Face Value

₹10

All Time Low / High

₹11.50 / 1923.00

TTK Healthcare stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Somewhat Overvalued

Check Valuation charts

Price Trend

Semi Strong

Check Price chart

Q.1 Is TTK Healthcare Ltd a good quality company?

TTK Healthcare Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does TTK Healthcare Ltd performance compare with that of its Peers?

Q.1 Revenue growth of TTK Healthcare Ltd vs industry peers?

TTK Healthcare Ltd revenue CAGR is 4.42%, compared to the industry median CAGR of 8.95%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of TTK Healthcare Ltd?

Promoters hold 74.56% of the TTK Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of TTK Healthcare Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -0.6% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	23.9%	18.6%	15.4%	15.5%	8.3%	8.4%	8.6%	10.1%	8.7%	10.6%	-
Value Creation Index ⓘ	0.7	0.3	0.1	0.1	-0.4	-0.4	-0.4	-0.3	-0.4	-0.2	-
Growth Parameters ⓘ
Sales ⓘ	519	528	578	628	646	476	599	725	753	801	857
Sales YoY Gr.	-	1.7%	9.4%	8.7%	2.9%	-26.3%	25.9%	21%	3.8%	6.5%	-
Adj EPS ⓘ	29.2	23.4	12.9	17.2	8.7	22.1	11.7	31.4	44.4	50.8	46.5
YoY Gr.	-	-20%	-44.7%	32.9%	-49.6%	155%	-46.9%	167.9%	41.3%	14.5%	-
BVPS (₹) ⓘ	169.7	197.1	161.8	174.8	173.1	205.4	230.2	671.6	705.2	750.6	785.9
Adj Net Profit ⓘ	22.7	18.1	18.3	24.3	12.2	31.2	16.6	44.4	62.7	71.8	66
Cash Flow from Ops. ⓘ	37.4	17.8	25.3	17.3	19.8	96.4	45	-24.8	-4.9	-4	-
Debt/CF from Ops. ⓘ	1	1.3	1.9	1.7	1.4	0.2	0.5	-1	-4.3	-5.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5%	4.4%	10.2%	6.5%
Adj EPS ⓘ	6.4%	42.5%	63.1%	14.5%
BVPSⓘ	18%	34.1%	48.3%	6.4%
Share Price	0%	6.7%	-9.9%	-29.6%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	17.8	12.4	9.4	10	4.9	11.5	5.3	6.9	6.4	7	6.1
Op. Profit Mgn % ⓘ	7.8	7.3	7.4	7.9	4.4	4.1	3.7	4.3	5	4.4	3.1
Net Profit Mgn % ⓘ	4.4	3.4	3.2	3.9	1.9	6.6	2.8	6.1	8.3	9	7.7
Debt to Equity ⓘ	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0	0	0	0
Working Cap Days ⓘ	73	70	76	93	102	134	97	95	131	162	255
Cash Conv. Cycle ⓘ	33	17	1	17	30	30	14	15	26	32	211

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	519	528	578	628	646	476	599	725	753	801
Operating Expenses ⓘ +	478	489	535	578	617	457	577	694	715	767
Manufacturing Costs	16	19	26	28	33	29	35	40	44	50
Material Costs	229	243	242	263	260	209	281	348	338	369
Employee Cost	81	88	120	131	144	94	103	123	133	151
Other Costs ⓘ	152	139	147	157	181	125	158	183	200	197
Operating Profit ⓘ	40	38	43	50	28	19	22	31	37	35
Operating Profit Margin (%)	7.8%	7.3%	7.4%	7.9%	4.4%	4.1%	3.6%	4.3%	5.0%	4.3%
Other Income ⓘ +	6	6	8	8	9	10	16	48	63	71
Exceptional Items ⓘ	0	0	0	0	0	8	2	0	0	14
Interest ⓘ	3	3	5	3	3	2	3	5	3	3
Depreciation ⓘ	7	12	15	15	14	13	13	13	13	8
Profit Before Tax ⓘ	36	29	30	39	19	23	25	62	84	108
Tax ⓘ	13	10	12	15	7	-14	6	17	21	27
Profit After Tax	23	19	18	24	12	37	19	45	63	82
PAT Margin (%)	4.4%	3.6%	3.2%	3.9%	1.9%	7.7%	3.1%	6.2%	8.4%	10.2%
Adjusted EPS (₹)	29.2	24.1	12.9	17.3	8.7	26.0	13.1	31.6	44.5	57.8
Dividend Payout Ratio (%)	17.10%	20.70%	38.90%	29%	34.40%	23.10%	76.30%	31.60%	22.50%	17.30%

Valuation of TTK Healthcare - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	136	157	233	251	249	295	330	953	1,001	1,065
Share Capital ⓘ	8	8	14	14	14	14	14	14	14	14
Reserves ⓘ	128	150	219	237	235	281	316	939	987	1,051
Debt +	23	23	47	28	28	18	20	26	21	22
Long Term Debt	1	1	1	0	0	0	0	0	0	0
Short Term Debt	22	22	46	28	28	18	20	26	21	22
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	33	67	86	73	87	98	103	111	102	107
Others Liabilities ⓘ	110	38	36	59	63	78	98	76	76	81
Total Liabilities ⓘ	303	285	403	411	427	488	551	1,166	1,201	1,275
Fixed Assets
Net Fixed Assets ⓘ +	106	99	110	98	89	85	80	71	75	81
Gross Block	146	111	141	144	149	159	165	164	178	183
Accumulated Depreciation	40	12	31	46	60	73	85	93	103	103
CWIP ⓘ	1	0	1	2	9	0	0	3	1	0
Investments ⓘ	10	9	9	13	9	13	15	13	13	11
Inventories	41	44	53	55	72	70	79	85	97	109
Trade Receivables	47	34	55	80	77	60	54	92	86	91
Cash Equivalents ⓘ	77	82	136	126	132	228	274	847	775	786
Others Assets ⓘ	20	17	39	37	40	31	50	55	154	197
Total Assets ⓘ	303	285	403	411	427	488	551	1,166	1,201	1,275

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	37	18	25	17	20	96	45	-25	-5	-4
PBT ⓘ	36	29	30	39	19	37	58	838	84	108
Adjustment ⓘ	10	10	13	10	7	-3	0	-803	-49	-81
Changes in Working Capital ⓘ	4	-13	-7	-19	4	42	-4	-44	-15	-3
Tax Paid ⓘ	-12	-8	-11	-13	-11	20	-9	-16	-25	-28
Cash Flow From Investing Activity ⓘ +	-27	5	-23	10	-13	-77	-30	32	28	20
Capex	-17	-5	-4	-4	-12	-2	-3	-11	-10	10
Net Investments	-10	6	-17	6	-10	-94	-41	-580	-19	-56
Others ⓘ	0	5	-2	7	8	18	14	624	57	65
Cash Flow From Financing Activity ⓘ +	-11	-23	-7	-31	-10	-17	-10	-12	-22	-18
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-3	-3	-5	-3	-3	-2	-4	-3	-3	-4
Dividend Paid ⓘ	-4	-5	-4	-9	-9	-4	-8	-14	-14	-14
Others ⓘ	-3	-15	1	-19	2	-11	2	5	-5	-0
Net Cash Flow ⓘ	-0	0	-4	-4	-4	2	5	-6	2	-2

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	18.46	13.16	9.52	10.25	5.01	13.76	6.02	7.01	6.46	7.94
ROCE (%)	23.85	18.63	15.42	15.46	8.28	8.38	8.59	10.13	8.72	10.63
Asset Turnover Ratio	1.8	1.8	1.68	1.54	1.54	1.04	1.15	0.88	0.67	0.67
PAT to CFO Conversion(x)	1.61	0.95	1.39	0.71	1.67	2.59	2.37	-0.56	-0.08	-0.05
Working Capital Days
Receivable Days	32	28	28.30	39.40	44.40	52.40	34.50	35.40	41.20	39.10
Inventory Days	27.70	29.40	30.50	31.50	35.90	54.40	45.50	39.70	41.90	45.40
Payable Days	50.50	75	115.60	110.50	111.80	160.50	130.40	112.50	115	103.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

TTK Healthcare Ltd FAQs

The current trading price of TTK Healthcare on 10-Jun-2026 11:47 is ₹920.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Jun-2026 the market cap of TTK Healthcare stood at ₹1,283 Cr

The latest P/E ratio of TTK Healthcare as of 09-Jun-2026 is 19.53.

The latest P/B ratio of TTK Healthcare as of 09-Jun-2026 is 1.16.

The 52-week high of TTK Healthcare is ₹1,402 and the 52-week low is ₹737.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of TTK Healthcare is ₹857 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that TTK Healthcare Ltd is a average quality company.

The key valuation ratios of TTK Healthcare Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of TTK Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About TTK Healthcare Ltd

T T K Healthcare Ltd was incorporated in 1958 and went public in the same year. The company's brand wagon consists of products that are sought after by a wide range of customers. The Woodward's Gripe Water brand is the market leader in the baby care category. The Eva range of personal care products (Talc, Deodorant, Skincare) bring together the gentle touch of nature, backed by TTK's extensive research.

TTK Healthcare has an All India sales and distribution network for marketing not only their own products, but also the KIWI Brand (Shoecare), Brylcreem (Haircare) and Kohinoor and Durex brands (Contraceptives). The company also specializes in sales and distribution in India as a joint venture partner. It has a successful tie up with Sara Lee Household and Bodycare Pvt. Ltd. and TTK-LIG Ltd. The company's distribution network comprises of 2800 redistribution stockists who cover both the urban and rural consumers.

TTK Healthcare has three Strategic Business Units

Pharamaceuticals Divison - TTK Healthcare's Pharmaceuticals Division has many breakthrough herbal and allopathic formulations, across various therapeutic segments. The range includes calcium supplements, haematinics, cervical dilators, thrombolytic agents, rejuvenators, multimineral supplements, liver correctives and pain management products.
Consumer Products Division - The Consumer Products Division(CPD) markets and distributes Woodward's Gripe Water - the undisputed market leader in the baby care category - and the recently introduced Woodward's Baby Soap. Besides handling the national distribution of Durex and Kohinoor condoms, the division also distributes Brylcreem Haircare and Toiletry Products and Kiwi's shoe care range.
Biomedical Devices Division- The TTK Heart Valve Division manufactures and distributes India's first indigenous heart valve prosthesis - the tilting-disc TTK Chitra Heart Valve. The only Indian-made heart valve, it is also the most price-friendly and so far nearly 18,000 Chitra valves have been successfully implanted in patients. Initially conceived in 1978, the heart valve being a critical implant, went through the most painstaking development for 12 years at the prestigious Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, India - an autonomous institute under the Department of Science and Technology, Government of India.

TTK the three letters that stand for quality consumer products at affordable prices. A reputation built across eight decades. An organization that started out as an indenting agency and grew to what it is today with path-breaking marketing ideas. Those core values that created TTK into a force to be reckoned with continue to define the framework of the TTK Group even today.

Product range of the company includes:

Personal care- Eva range of womenâ€™s personal care products

Pharmaceuticals

Calcium Supplement Range
Delivery Care Range
Women's Care Range
Haematinic Range
Pain Management Range
Neurotrophic Range
Gastro Intestinal Range
Male Fertility Range
Nutritional Range
Cardiac Care Range

Baby Care:

Woodwardâ€™s Baby Bath
Woodwardâ€™s Gripe Water

Animal Care

Livestock- Wide range of medicines, tonics and productivity boosters.
Poultry- High quality medicines and feed supplements for good productivity
Medicines, tonics and supplements for Pets.

Heart Valve - India's first indigenous heart valve prosthesis - the tilting-disc TTK Chitra Heart Valve.

Food - TTK Ready-to-fry Snack Pellets are available in a variety of flavors, shapes, colours and designs

Maps- The Publications Division of TTK Healthcare is the largest producer of maps and map-based publications in the private sector.

Achievements/ recognition:

Besides being the first pharmaceutical company in India to be awarded the ISO certification by BIS, TTK Healthcare was also the first to launch technology-driven life-saving products like Urokinase and Dopamine.
The first company to launch technology driven life saving products like Urokinase and Dopamine
The first to develop a product based on traditional knowledge - LACTARE for Lactation

TTK Healthcare Ltd (TTKHLTCARE)

TTK Healthcare Ltd (TTKHLTCARE)

TTK Healthcare stock performance